Most conditions are still poorly treated, with low therapeutic response rates. Whether it’s cancer, metabolic, neurodegenerative or immune diseases, there is a faster and less expensive way to reach better outcomes. ABCureD accelerates and optimizes the roadmap from research lab to clinic. We thrive on the momentum, transition from hypothesis-driven to big-data-driven development. Artificial Intelligence is changing the way we conduct R&D in biomedicine.